Report Detail

Pharma & Healthcare Global Buprenorphine Hydrochloride Market Growth 2019-2024

  • RnM3035368
  • |
  • 27 February, 2019
  • |
  • Global
  • |
  • 163 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Buprenorphine hydrochloride, a white crystalline powder, is a semisynthetic opioid analgesic used for the relief of moderate to severe pain. It is in the same chemical family of morphine, codeine and heroin. However, buprenorphine hydrochloride has the distinction of producing less euphoric effects than those drugs.
USA is the dominate consumer in buprenorphine hydrochloride industry. The sales volume of USA was 5312 kg in 2015, occupied about 48.11% of the total amount. Europe is the second one, with the sales volume of 4222 kg, and the sales market share of 38.24% in 2015.

According to this study, over the next five years the Buprenorphine Hydrochloride market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Buprenorphine Hydrochloride business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Buprenorphine Hydrochloride market by product type, application, key manufacturers and key regions and countries.

This study considers the Buprenorphine Hydrochloride value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Type I
Type II
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Analgesic
Opioid Antagonist

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Siegfried
Sanofi
Johnson Matthey
Mallinckrodt
Noramco
Unichemlabs
Arevipharma
Resonance-labs
Sun Pharma
Rusan Pharma
Micro Orgo Chem
Faranshimi

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Buprenorphine Hydrochloride consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Buprenorphine Hydrochloride market by identifying its various subsegments.
Focuses on the key global Buprenorphine Hydrochloride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Buprenorphine Hydrochloride with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Buprenorphine Hydrochloride submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Buprenorphine Hydrochloride Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Buprenorphine Hydrochloride Consumption 2014-2024
        • 2.1.2 Buprenorphine Hydrochloride Consumption CAGR by Region
      • 2.2 Buprenorphine Hydrochloride Segment by Type
        • 2.2.1 Type I
        • 2.2.2 Type II
      • 2.3 Buprenorphine Hydrochloride Consumption by Type
        • 2.3.1 Global Buprenorphine Hydrochloride Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Buprenorphine Hydrochloride Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Buprenorphine Hydrochloride Sale Price by Type (2014-2019)
      • 2.4 Buprenorphine Hydrochloride Segment by Application
        • 2.4.1 Analgesic
        • 2.4.2 Opioid Antagonist
      • 2.5 Buprenorphine Hydrochloride Consumption by Application
        • 2.5.1 Global Buprenorphine Hydrochloride Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Buprenorphine Hydrochloride Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Buprenorphine Hydrochloride Sale Price by Application (2014-2019)

      3 Global Buprenorphine Hydrochloride by Players

      • 3.1 Global Buprenorphine Hydrochloride Sales Market Share by Players
        • 3.1.1 Global Buprenorphine Hydrochloride Sales by Players (2017-2019)
        • 3.1.2 Global Buprenorphine Hydrochloride Sales Market Share by Players (2017-2019)
      • 3.2 Global Buprenorphine Hydrochloride Revenue Market Share by Players
        • 3.2.1 Global Buprenorphine Hydrochloride Revenue by Players (2017-2019)
        • 3.2.2 Global Buprenorphine Hydrochloride Revenue Market Share by Players (2017-2019)
      • 3.3 Global Buprenorphine Hydrochloride Sale Price by Players
      • 3.4 Global Buprenorphine Hydrochloride Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Buprenorphine Hydrochloride Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Buprenorphine Hydrochloride Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Buprenorphine Hydrochloride by Regions

      • 4.1 Buprenorphine Hydrochloride by Regions
        • 4.1.1 Global Buprenorphine Hydrochloride Consumption by Regions
        • 4.1.2 Global Buprenorphine Hydrochloride Value by Regions
      • 4.2 Americas Buprenorphine Hydrochloride Consumption Growth
      • 4.3 APAC Buprenorphine Hydrochloride Consumption Growth
      • 4.4 Europe Buprenorphine Hydrochloride Consumption Growth
      • 4.5 Middle East & Africa Buprenorphine Hydrochloride Consumption Growth

      5 Americas

      • 5.1 Americas Buprenorphine Hydrochloride Consumption by Countries
        • 5.1.1 Americas Buprenorphine Hydrochloride Consumption by Countries (2014-2019)
        • 5.1.2 Americas Buprenorphine Hydrochloride Value by Countries (2014-2019)
      • 5.2 Americas Buprenorphine Hydrochloride Consumption by Type
      • 5.3 Americas Buprenorphine Hydrochloride Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Buprenorphine Hydrochloride Consumption by Countries
        • 6.1.1 APAC Buprenorphine Hydrochloride Consumption by Countries (2014-2019)
        • 6.1.2 APAC Buprenorphine Hydrochloride Value by Countries (2014-2019)
      • 6.2 APAC Buprenorphine Hydrochloride Consumption by Type
      • 6.3 APAC Buprenorphine Hydrochloride Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Buprenorphine Hydrochloride by Countries
        • 7.1.1 Europe Buprenorphine Hydrochloride Consumption by Countries (2014-2019)
        • 7.1.2 Europe Buprenorphine Hydrochloride Value by Countries (2014-2019)
      • 7.2 Europe Buprenorphine Hydrochloride Consumption by Type
      • 7.3 Europe Buprenorphine Hydrochloride Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Buprenorphine Hydrochloride by Countries
        • 8.1.1 Middle East & Africa Buprenorphine Hydrochloride Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Buprenorphine Hydrochloride Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Buprenorphine Hydrochloride Consumption by Type
      • 8.3 Middle East & Africa Buprenorphine Hydrochloride Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Buprenorphine Hydrochloride Distributors
      • 10.3 Buprenorphine Hydrochloride Customer

      11 Global Buprenorphine Hydrochloride Market Forecast

      • 11.1 Global Buprenorphine Hydrochloride Consumption Forecast (2019-2024)
      • 11.2 Global Buprenorphine Hydrochloride Forecast by Regions
        • 11.2.1 Global Buprenorphine Hydrochloride Forecast by Regions (2019-2024)
        • 11.2.2 Global Buprenorphine Hydrochloride Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Buprenorphine Hydrochloride Forecast by Type
      • 11.8 Global Buprenorphine Hydrochloride Forecast by Application

      12 Key Players Analysis

      • 12.1 Siegfried
        • 12.1.1 Company Details
        • 12.1.2 Buprenorphine Hydrochloride Product Offered
        • 12.1.3 Siegfried Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Siegfried News
      • 12.2 Sanofi
        • 12.2.1 Company Details
        • 12.2.2 Buprenorphine Hydrochloride Product Offered
        • 12.2.3 Sanofi Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Sanofi News
      • 12.3 Johnson Matthey
        • 12.3.1 Company Details
        • 12.3.2 Buprenorphine Hydrochloride Product Offered
        • 12.3.3 Johnson Matthey Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Johnson Matthey News
      • 12.4 Mallinckrodt
        • 12.4.1 Company Details
        • 12.4.2 Buprenorphine Hydrochloride Product Offered
        • 12.4.3 Mallinckrodt Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Mallinckrodt News
      • 12.5 Noramco
        • 12.5.1 Company Details
        • 12.5.2 Buprenorphine Hydrochloride Product Offered
        • 12.5.3 Noramco Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Noramco News
      • 12.6 Unichemlabs
        • 12.6.1 Company Details
        • 12.6.2 Buprenorphine Hydrochloride Product Offered
        • 12.6.3 Unichemlabs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Unichemlabs News
      • 12.7 Arevipharma
        • 12.7.1 Company Details
        • 12.7.2 Buprenorphine Hydrochloride Product Offered
        • 12.7.3 Arevipharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Arevipharma News
      • 12.8 Resonance-labs
        • 12.8.1 Company Details
        • 12.8.2 Buprenorphine Hydrochloride Product Offered
        • 12.8.3 Resonance-labs Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Resonance-labs News
      • 12.9 Sun Pharma
        • 12.9.1 Company Details
        • 12.9.2 Buprenorphine Hydrochloride Product Offered
        • 12.9.3 Sun Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Sun Pharma News
      • 12.10 Rusan Pharma
        • 12.10.1 Company Details
        • 12.10.2 Buprenorphine Hydrochloride Product Offered
        • 12.10.3 Rusan Pharma Buprenorphine Hydrochloride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Rusan Pharma News
      • 12.11 Micro Orgo Chem
      • 12.12 Faranshimi

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Buprenorphine Hydrochloride . Industry analysis & Market Report on Buprenorphine Hydrochloride is a syndicated market report, published as Global Buprenorphine Hydrochloride Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Buprenorphine Hydrochloride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,917.02
      4,375.53
      5,834.04
      3,400.14
      5,100.21
      6,800.28
      559,723.80
      839,585.70
      1,119,447.60
      305,317.20
      457,975.80
      610,634.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report